Paraplegia following Chemonucleolysis A Case Report and Discussion of Neurotoxicity.
- Author:
Dae Il CHANG
1
;
Ju Han KIM
;
Myung Ho KIM
Author Information
1. Department of Neurology, College of Medicine, Hanyang University.
- Publication Type:Case Report
- MeSH:
Animals;
Chymopapain;
Humans;
Intervertebral Disc Chemolysis*;
Paraplegia*
- From:Journal of the Korean Neurological Association
1986;4(2):231-234
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Chymopapain was discovered by Jensen in 1941, and in 1963 Smith demonstrated the chondrolytic properties of chymopapain. Since then, many patients have been injected with this agent. Although there are evidences of neurotoxicity to chymopapain in animals, adverse effects in humans have rarely been reported. We present a case delayed onset of paraplegia after chymopapain chemonucleolysis and review the neurotoxicities to chymopapain.
